CSLLY
Price
$64.43
Change
-$0.41 (-0.63%)
Updated
Sep 25 closing price
Capitalization
62.06B
MLYS
Price
$39.99
Change
+$1.48 (+3.84%)
Updated
Sep 26 closing price
Capitalization
3.1B
45 days until earnings call
Interact to see
Advertisement

CSLLY vs MLYS

Header iconCSLLY vs MLYS Comparison
Open Charts CSLLY vs MLYSBanner chart's image
CSL
Price$64.43
Change-$0.41 (-0.63%)
Volume$222.83K
Capitalization62.06B
Mineralys Therapeutics
Price$39.99
Change+$1.48 (+3.84%)
Volume$1.64M
Capitalization3.1B
CSLLY vs MLYS Comparison Chart in %
Loading...
CSLLY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MLYS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CSLLY vs. MLYS commentary
Sep 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CSLLY is a Hold and MLYS is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 27, 2025
Stock price -- (CSLLY: $64.07 vs. MLYS: $39.99)
Brand notoriety: CSLLY and MLYS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CSLLY: 103% vs. MLYS: 94%
Market capitalization -- CSLLY: $62.06B vs. MLYS: $3.1B
CSLLY [@Biotechnology] is valued at $62.06B. MLYS’s [@Biotechnology] market capitalization is $3.1B. The market cap for tickers in the [@Biotechnology] industry ranges from $98.9B to $0. The average market capitalization across the [@Biotechnology] industry is $1.9B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CSLLY’s FA Score shows that 1 FA rating(s) are green whileMLYS’s FA Score has 0 green FA rating(s).

  • CSLLY’s FA Score: 1 green, 4 red.
  • MLYS’s FA Score: 0 green, 5 red.
According to our system of comparison, MLYS is a better buy in the long-term than CSLLY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CSLLY’s TA Score shows that 4 TA indicator(s) are bullish while MLYS’s TA Score has 4 bullish TA indicator(s).

  • CSLLY’s TA Score: 4 bullish, 4 bearish.
  • MLYS’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, CSLLY is a better buy in the short-term than MLYS.

Price Growth

CSLLY (@Biotechnology) experienced а -2.00% price change this week, while MLYS (@Biotechnology) price change was +1.83% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.00%. For the same industry, the average monthly price growth was +9.18%, and the average quarterly price growth was +54.60%.

Reported Earning Dates

MLYS is expected to report earnings on Nov 11, 2025.

Industries' Descriptions

@Biotechnology (+4.00% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CSLLY($62.1B) has a higher market cap than MLYS($3.1B). MLYS YTD gains are higher at: 224.858 vs. CSLLY (-24.930). CSLLY has more cash in the bank: 1.52B vs. MLYS (325M).
CSLLYMLYSCSLLY / MLYS
Capitalization62.1B3.1B2,002%
EBITDAN/A-203.01M-
Gain YTD-24.930224.858-11%
P/E Ratio20.77N/A-
RevenueN/A0-
Total Cash1.52B325M469%
Total Debt12BN/A-
FUNDAMENTALS RATINGS
CSLLY: Fundamental Ratings
CSLLY
OUTLOOK RATING
1..100
58
VALUATION
overvalued / fair valued / undervalued
1..100
2
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
85
P/E GROWTH RATING
1..100
90
SEASONALITY SCORE
1..100
75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CSLLYMLYS
RSI
ODDS (%)
Bullish Trend 2 days ago
69%
Bearish Trend 2 days ago
71%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
58%
Bearish Trend 2 days ago
89%
Momentum
ODDS (%)
Bearish Trend 2 days ago
66%
Bullish Trend 2 days ago
81%
MACD
ODDS (%)
Bullish Trend 2 days ago
51%
Bearish Trend 2 days ago
86%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
66%
Bearish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
64%
Bullish Trend 2 days ago
83%
Advances
ODDS (%)
Bullish Trend 23 days ago
52%
Bullish Trend 18 days ago
87%
Declines
ODDS (%)
Bearish Trend 2 days ago
66%
Bearish Trend 4 days ago
85%
BollingerBands
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
63%
Bullish Trend 2 days ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
CSLLY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MLYS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HAMVX28.690.31
+1.09%
Harbor Mid Cap Value Instl
TRIEX28.120.24
+0.86%
Nuveen International Eq Idx Retire
LVAGX17.220.13
+0.76%
LSV Global Value Investor
FBFZX12.770.05
+0.39%
Franklin Managed Income Adv
PALRX19.100.06
+0.32%
PGIM Balanced R

CSLLY and

Correlation & Price change

A.I.dvisor tells us that CSLLY and ADAP have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CSLLY and ADAP's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CSLLY
1D Price
Change %
CSLLY100%
N/A
ADAP - CSLLY
32%
Poorly correlated
+18.03%
MLYS - CSLLY
32%
Poorly correlated
+3.82%
CDXS - CSLLY
31%
Poorly correlated
+2.29%
SEER - CSLLY
30%
Poorly correlated
+2.73%
ADPT - CSLLY
30%
Poorly correlated
+0.61%
More

MLYS and

Correlation & Price change

A.I.dvisor indicates that over the last year, MLYS has been loosely correlated with CYTK. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if MLYS jumps, then CYTK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MLYS
1D Price
Change %
MLYS100%
+3.84%
CYTK - MLYS
54%
Loosely correlated
+5.37%
IONS - MLYS
52%
Loosely correlated
+1.78%
BIESF - MLYS
45%
Loosely correlated
N/A
NEVPF - MLYS
43%
Loosely correlated
N/A
PTGX - MLYS
39%
Loosely correlated
+4.20%
More